1. High‐dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft‐versus‐host disease. (18th August 2019) Authors: Blanchard, S.K.; Sullivan, K.M.; Hooten, J.N.; Holcomb, Z. E.; Rowe Nichols, K.; Selim, M.A.; Rao, C.L.; Hall, R.P.; Chao, N.J.; Cardones, A.R. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High‐dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft‐versus‐host disease. (1st October 2019) Authors: Blanchard, S.K.; Sullivan, K.M.; Hooten, J.N.; Holcomb, Z. E.; Rowe Nichols, K.; Selim, M.A.; Rao, C.L.; Hall, R.P.; Chao, N.J.; Cardones, A.R. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗